Caribou Biosciences, Inc.
CRBU
$1.97
$0.063.14%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 25.36% | 20.57% | -43.51% | 3.01% | -2.85% |
| Total Depreciation and Amortization | -42.40% | -46.39% | 36.33% | 64.08% | 60.00% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -0.73% | -14.41% | 2,065.08% | -13.74% | -57.38% |
| Change in Net Operating Assets | 143.40% | 50.11% | -80.64% | -76.21% | -185.63% |
| Cash from Operations | 41.29% | 22.89% | 14.02% | 1.28% | -65.91% |
| Capital Expenditure | 141.70% | 82.91% | 81.35% | 28.04% | 77.25% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 8.03% | -59.67% | 4.32% | 106.62% | 156.29% |
| Cash from Investing | 12.81% | -59.09% | 13.38% | 115.11% | 150.61% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 5.36% | 13.52% | -95.45% | -96.25% | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 5.36% | 13.52% | -95.45% | -96.25% | 9,083.72% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 107.76% | -138.42% | 63.45% | 844.84% | 70.36% |